Poor outcome in end-stage heart failure patients with low circulating calcitriol levels. - Wikidata - thesis-toulmin - TriplyDB

Poor outcome in end-stage heart failure patients with low circulating calcitriol levels.

Poor outcome in end-stage heart failure patients with low circulating calcitriol levels.

http://www.wikidata.org/entity/Q44236488

about

Serum 25-hydroxyvitamin D is not related to cardiac natriuretic peptide in nulliparous and lactating women.Serum vitamin D levels in Indian patients with retinal venous occlusions.Vitamin D deficiency in the spontaneously hypertensive heart failure [SHHF] prone rat.Vitamin D in organ transplantation Genetic variation in CYP27B1 is associated with congestive heart failure in patients with hypertension.An estimate of the survival benefit of improving vitamin D status in the adult german population.Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited Intracellular calcium overloading and oxidative stress in cardiomyocyte necrosis via a mitochondriocentric signal-transducer-effector pathway.1,25-Dihydroxyvitamin D to PTH(1-84) Ratios Strongly Predict Cardiovascular Death in Heart Failure.Disturbances in calcium metabolism and cardiomyocyte necrosis: the role of calcitropic hormones.Calciotropic and Phosphaturic Hormones in End-Stage Heart Failure Patients Supported by a Left-Ventricular Assist Device.Clinical and laboratory determinants of low serum level of 25-hydroxyvitamin D during escalation of pharmacotherapy in heart failure patients.Mineralocorticoid receptor antagonism confers cardioprotection in heart failure.Vitamin D signaling pathway plays an important role in the development of heart failure after myocardial infarction.Role of vitamin d in cardiometabolic diseases Relation of vitamin D status to congestive heart failure and cardiovascular events in dogs Calcidiol deficiency in end-stage organ failure and after solid organ transplantation: status quo.Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium.Vitamin D affects survival independently of vascular calcification in chronic kidney disease.Solar ultraviolet-B irradiance and vitamin D may reduce the risk of septicemia.Vitamin D and the heart.Mean platelet volume and vitamin D level.Is vitamin D deficiency associated with heart failure? A review of current evidence.Mineral metabolism abnormalities and vitamin D receptor activation in cardiorenal syndromes.Vitamin d and stage 5 chronic kidney disease: a new paradigm?Parathyroid hormone, a crucial mediator of pathologic cardiac remodeling in aldosteronism.Interplay of parathyroid hormone and aldosterone antagonist in prevention of heart failure hospitalizations in chronic kidney disease.Vitamin D supplements reduce depressive symptoms and cardiac events in heart failure patients with moderate to severe depressive symptoms.Vitamin D and Heart Failure.Vitamin D levels predict hospitalization and mortality in patients with heart failure.Vitamin D status: to be considered in heart failure patients!Vitamin D3 repletion versus placebo as adjunctive treatment of heart failure patient quality of life and hormonal indices: a randomized, double-blind, placebo-controlled trial.Vitamin D supplementation and bone turnover in advanced heart failure: the EVITA trial.Vitamin d and cardiovascular disease.Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome.Vitamin D status and outcomes in heart failure patients.The vitamin D system: a crosstalk between the heart and kidney.Vitamin D and Cardiovascular Disease Vitamin D and cardiovascular disease Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure

P2860

Q33403893-220E384F-457B-4C97-925C-F0E1D41D5400 Q33702648-0A6D0468-DEA1-4A12-858F-E6BFCDE33505 Q33927901-A9D207AB-0783-443C-93D8-A42A898F51DD Q34069825-0FE6B53E-73BA-44FB-BD9C-0E123B70CEEE Q34283862-96F6B609-E200-4C82-B7F2-DDF20253426D Q34974614-2687D994-5CC3-4B57-9E7B-F24B56990DC0 Q35138063-4D742767-4F0C-4F75-951A-10016A77FEEB Q35500640-129B6932-1CBC-422B-93BE-E6C8027558F5 Q35755817-EF542F41-2688-489A-8AFD-1DAAB50945F8 Q36114162-9BB00D4A-B64B-40EF-9D85-88976AE1660B Q36176069-38E7A68A-BF32-4FB7-BC54-B3ECE4DF01B3 Q36245483-1D8532ED-1F64-487D-B655-773C003C3FA3 Q36597950-C885644E-7339-4F77-95AD-3285B6D110A7 Q36787402-4F1FC522-5F81-406D-ACBE-C1757FCB2CC4 Q36825786-485A82FE-00C0-4A6F-95E6-354DB91933C0 Q36975263-F9C016F1-9691-448C-A9D7-57714730A1B1 Q37083762-4D1F5514-B021-4675-BCF4-1C444C7455A0 Q37090568-A0E9C415-F99D-4225-BE33-344D5566276A Q37211081-184E0965-F0C7-40A0-A003-361911E365C0 Q37273516-7DA1426C-3C6E-448D-84E1-668035035BA6 Q37342339-B0C24F82-AD48-4F6A-A5D0-F72A39D62013 Q37628856-1EFC78B2-1CFE-4E3E-AE05-B1C387FA1D78 Q37838145-51AB0562-0AB1-4214-8754-D46E2A97F051 Q37843788-5B8C645B-D497-49B7-B957-BE75AAD149EE Q37941837-73117446-CEB0-445E-81B8-5C8B96C3D3E3 Q37988979-35A59CC0-C4CD-431F-ACF1-404B639BFE69 Q38227113-49B3458B-238D-4476-B722-8AC5360FA585 Q38614517-2CC67BE0-BE8B-41A3-9799-4BBC104B7927 Q38624627-AAE68FF5-5467-4837-BCEB-DA05515A1D93 Q41332839-B1CB2CC7-43DE-4FEC-9EB3-AA5425CD8E02 Q43706682-19B1BEF0-BA53-4ECE-B77E-BD8A16D0D2CF Q47169224-83ADC2EF-755B-485F-AD9D-985DE5649D86 Q47279236-B05A048E-A98A-4F67-B50A-4A2E0EA177C3 Q50937532-DE9EAE16-1750-42FC-B20D-1E207F449258 Q51362664-6B6BD7B0-EF15-484D-BC02-42227F19F6F1 Q51467888-7BCDE02F-78C2-48FE-A29D-13A31FA5BA11 Q53314344-B67810E2-2027-44F5-9B32-8741743E8F9E Q56909935-FCC3EE96-1799-4252-812B-7A155FA61E4E Q57657017-6DAEAF48-798D-4FAD-B760-965708D3F432 Q57909796-0BD6494A-40E3-46D1-B4E0-1D8F812DC33F

P2860

Poor outcome in end-stage heart failure patients with low circulating calcitriol levels.

http://www.wikidata.org/entity/Q44236488

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Poor outcome in end-stage heart failure patients with low circulating calcitriol levels.

@en

Poor outcome in end-stage heart failure patients with low circulating calcitriol levels.

@nl

type

label

Poor outcome in end-stage heart failure patients with low circulating calcitriol levels.

@en

Poor outcome in end-stage heart failure patients with low circulating calcitriol levels.

@nl

prefLabel

Poor outcome in end-stage heart failure patients with low circulating calcitriol levels.

@en

Poor outcome in end-stage heart failure patients with low circulating calcitriol levels.

@nl

P1433

Q44236488-B32F9D24-F8DB-4E23-9647-67E99975D7F7

P1476

Q44236488-5975B5C2-E1F2-4642-BB9F-EB1E64FCF158

P2093

Q44236488-21BCBE70-2C1F-4565-B5BC-B39732F2E7B2

Q44236488-36C9BEC3-E8DD-44AD-B28F-5938D87166AA

Q44236488-4CAB9BC6-2C3A-4D83-86DC-003645BA85CD

Q44236488-557890F3-E039-4C81-AA61-BAA1B52121B7

Q44236488-A92D44FD-CE72-401C-8C8E-25B7CF77AAE2

Q44236488-AF75708B-B9CE-45F8-B162-66944A30AA4F

Q44236488-C800909A-6594-420C-9CD9-ADFD7610387A

Q44236488-F0D64961-CB83-42D3-AED6-B941579ED64F

P2860

Q44236488-0703B758-15BD-4C38-9F76-42776B0D7476

Q44236488-0AB04A6B-19F3-45DD-A076-8D4B6C83CEDB

Q44236488-1B2F5EE4-E74A-4522-977F-0793B811F35C

Q44236488-33761E1E-0E66-446A-8F7D-D138748DE833

Q44236488-3417593C-7D69-4EEA-BF23-AFBCEF3C6936

Q44236488-3DD60ECF-7B82-498F-8EDE-7BAF2D545F7B

Q44236488-41A29E89-650D-41D3-AACE-19E18BCDBDE6

Q44236488-472EADD9-EAFC-4B10-83ED-11C2BE5DA653

Q44236488-4B56498A-0A46-4B67-B064-6272E8B74B20

Q44236488-6F956B93-513E-429D-BDB9-1EB23828D7FE

P304

Q44236488-44F3EBA2-D371-4978-B555-79382AD440E4

P31

Q44236488-1A50C098-FB1B-4EF9-A4A5-884D980EF572

P356

Q44236488-445E7597-EF26-442D-8822-5BAAB4B0E963

P433

Q44236488-DE6AFF3B-5580-4FB7-AD98-3E5329B276E6

P478

Q44236488-D66EB390-98DF-4550-94E8-94042682025B

P50

Q44236488-9F1B098F-5FF1-4F18-A238-63D752307442

P577

Q44236488-5C73159D-05BD-4DAC-989D-F208A0FDAC3B

P5875

Q44236488-312ABB45-0FF6-4E12-B62C-4AD1E4AD0DC9

P698

Q44236488-AB6B0927-57C0-465B-8156-D683A07113E6

P356

J.EJHEART.2008.01.013

P1433

European Journal of Heart Failure

P1476

Poor outcome in end-stage heart failure patients with low circulating calcitriol levels.

@en

P2093

Christian Götting

http://www.w3.org/2001/XMLSchema#string

Gero Tenderich

http://www.w3.org/2001/XMLSchema#string

Joachim Kuhn

http://www.w3.org/2001/XMLSchema#string

Knut Kleesiek

http://www.w3.org/2001/XMLSchema#string

Oxana Dronow

http://www.w3.org/2001/XMLSchema#string

Reiner Koerfer

http://www.w3.org/2001/XMLSchema#string

Stefanie S Schleithoff

http://www.w3.org/2001/XMLSchema#string

Uwe Fuchs

http://www.w3.org/2001/XMLSchema#string

P2860

Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials.

Matrix metalloproteinases: regulation and dysregulation in the failing heart.

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.

Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation.

Vitamin D and disease prevention with special reference to cardiovascular disease.

Vitamin D insufficiency in congestive heart failure: why and what to do about it?

Overall tolerance and safety of quinapril in clinical trials.

Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse.

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population.

P304

321-327

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EJHEART.2008.01.013

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Armin Zittermann

P577

2008-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5547349

http://www.w3.org/2001/XMLSchema#string

P698

18304873

http://www.w3.org/2001/XMLSchema#string